In Slico Study of Green Tea (Camellia Sinensis) Extract Epigallocatechine Gallate as an Inhibitor of Alzheimer's and Myositis Using Beta Secretase 1

https://doi.org/10.24036/sainstek/vol2-iss02/32

Authors

  • Mohamad Zarqani Bin Yeop Chemical Engineering Studies, College of Engineering, Universiti Teknologi MARA Johor Branch , Pasir Gudang Campus, Bandar Seri Alam, Malaysia
  • Alifah Humaira Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Padang, Indonesia
  • Rismi Verawati Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Padang, Indonesia
  • Vira Marcella Winokan Department of Medicine, Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Indonesia
  • Rauza Sukma Rita Department of Biochemistry, Faculty of Medicine, Universitas Andalas, Indonesia
  • Himmatul Barroroh Chemistry Department, Faculty of Science and Technology, Universitas Islam Negeri Maulana Malik Ibrahim, Jl. Gajayana No.50 Malang, East of Java, Indonesia
  • Herland Satriawan Institute of Ocean and Earth Sciences, University of Malaya, 50603, Kuala Lumpur, Malaysia

Keywords:

Epigallocatechine Gallate, Alzheimer, Myositis, Beta Secretase 1, In Silico

Abstract

This research entitled "In Silico Study of Epigallocatechine Gallate Green Tea Extract (Camellia Sinensis) as an Alzheimer and Myositis Inhibitor Using Beta Secretase 1" examines the effectiveness of epigallocatechine gallate (EGCG) as an inhibitor of Alzheimer and Myositis. The research method used is in silico with PyMOL and Pyrex software for molecular simulation and Protein Plus for protein interaction analysis. Analysis of binding affinity calculations showed values of -8.1, -8.1, and -8.0 with RMSD values of 0, 1.443, and 1.767. This study produced evidence that there is an interaction between EGCG and Beta Secretase 1 which illustrates the potential of EGCG as an inhibitor of Alzheimer's and Myositis. Lepinski Rule analysis showed that EGCG has a molecular weight of 448, 8 hydrogen bond donors, 11 hydrogen bond acceptors, a log P value of -3.316 and a molar reactivity of 93.0303. These conclusions indicate that EGCG meets the criteria of Lepinski's rule as a good drug candidate, and therefore shows potential as a therapeutic agent in the treatment of Alzheimer's and Myositis.

References

. Liu, Q. Y., Koukiekolo, R., Zhang, D. L., Smith, B., Ly, D., Lei, J. X., & Ghribi, O., "Molecular events linking cholesterol to Alzheimer’s disease and inclusion body myositis in a rabbit model", American Journal of Neurodegenerative Disease, 2016, 5(1), 74.

. Catalán, M., Selva-O'Callaghan, A., & Grau, J. M., "Diagnosis and classification of sporadic inclusion body myositis (sIBM)", Autoimmunity Reviews, 2014, 13(4-5), 363-366.

. Zhang, Y., Li, K., Pu, C., Dang, H., Liu, J., & Shi, Q., "A novel application of tau PET in the diagnosis of sporadic inclusion body myositis: a case report", Medicine, 2020, 99(31).

. Yan, R., & Vassar, R., "Targeting the β secretase BACE1 for Alzheimer's disease therapy", The Lancet Neurology, 2014, 13(3), 319-329.

. Hampel, H., Vassar, R., De Strooper, B., Hardy, J., Willem, M., Singh, N., ... & Vergallo, A., "The β-secretase BACE1 in Alzheimer’s disease", Biological Psychiatry, 2021, 89(8), 745-756.

. Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J., "BACE1: More than just a β‐secretase", Obesity Reviews, 2022, 23(7), e13430.

. Cervellati, C., Trentini, A., Rosta, V., Passaro, A., Bosi, C., Sanz, J. M., ... & Zuliani, G., "Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease", GeroScience, 2020, 42, 159-167.

. McDade, E., Voytyuk, I., Aisen, P., Bateman, R. J., Carrillo, M. C., De Strooper, B., ... & Lichtenthaler, S. F., "The case for low-level BACE1 inhibition for the prevention of Alzheimer disease", Nature Reviews Neurology, 2021, 17(11), 703-714.

. Henríquez, G., Gomez, A., Guerrero, E., & Narayan, M., "Potential role of natural polyphenols against protein aggregation toxicity: in vitro, in vivo, and clinical studies", ACS Chemical Neuroscience, 2020, 11(19), 2915-2934.

. Koynova, R., & Tenchov, B., "Natural product formulations for the prevention and treatment of Alzheimer's disease: a patent review", Recent Patents on Drug Delivery & Formulation, 2018, 12(1), 23-39.

. Zhang, Z. X., Li, Y. B., & Zhao, R. P., "Epigallocatechin gallate attenuates β-amyloid generation and oxidative stress involvement of PPARγ in N2a/APP695 cells", Neurochemical Research, 2017, 42, 468-480.

. Park, S. H., Yang, E. J., Kim, S. I., & Song, K. S., "β-Secretase (BACE1)-inhibiting C-methylrotenoids from Abronia nana suspension cultures", Bioorganic & Medicinal Chemistry Letters, 2014, 24(13), 2945-2948.

. Mori, T., Koyama, N., Tan, J., Segawa, T., Maeda, M., & Town, T., "Combined treatment with the phenolics (−)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice", Journal of Biological Chemistry, 2019, 294(8), 2714-5444.

. Manalo, R. V., Silvestre, M. A., Barbosa, A. L. A., & Medina, P. M., "Coconut (Cocos nucifera) ethanolic leaf extract reduces Amyloid-β (1-42) aggregation and paralysis prevalence in transgenic Caenorhabditis elegans independently of free radical scavenging and acetylcholinesterase inhibition", Biomedicines, 2017, 5(2), 17.

. Link, P., "Natural products against neurodegenerative diseases: effects in the model organism Caenorhabditis elegans", Doctoral dissertation, 2018.

. Su, T., Monte, W. C., Hu, X., He, Y., & He, R., "Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment", Current Topics in Medicinal Chemistry, 2016, 16(5), 472-484.

. Rabaan, A. A., Halwani, M. A., Aljeldah, M., Al Shammari, B. R., Garout, M., Aldali, J., ... & Alsayyah, A., "Exploration of potent antiviral phytomedicines from Lauraceae family plants against SARS-CoV-2 RNA-dependent RNA polymerase", Journal of Biomolecular Structure and Dynamics, 2023, 1-21.

. Murtadlo, A. A. A., Listiyani, P., Utami, S. L., Wahyuningsih, S., Turista, D. D. R., Wiguna, A., ... & Ullah, M. E., "Molecular Docking Study of Nigella sativa Bioactive Compound as E6 Inhibitor Against Human Papillomavirus (HPV) Infection", SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics, 2022, 1(02), 32-38.

. Rosalina, L., Purnamasari, D., Verawati, R., Suryani, O., Ghifari, M. A., Putri, A., ... & Ansori, A. N. M., "In Silico Study on the Inhibition of Sitogluside from Clove Plant (Syzygium aromaticum) on Interleukin 2 in B and T Cell Proliferation", Pharmacognosy Journal, 2023, 15(4).

. Kharisma, V. D., Ansori, A. N. M., Dian, F. A., Rizky, W. C., Dings, T. G. A., Zainul, R., & Nugraha, A. P., "Molecular Docking And Dynamic Simulation Of Entry Inhibitor From Tamarindus Indica Bioactive Compounds Against Sars-Cov-2 Infection Via Viroinformatics Study", Biochemical and Cellular Archives, 2021, 21(2), 3323-3327.

. Islamiati, Y., Suryani, Y., Adawiyah, A., Taufiqurrohman, O., Kharisma, V. D., Purnamasari, D., ... & Albari, M. T., "The Potential of Antivirus Compounds in Gletang (Tridax procumbens Linn.) in Inhibiting 3CLpro Receptor of SARS-CoV-2 Virus by In Silico", Pharmacognosy Journal, 2022, 14(6).

. Ullah, M. E., Probojati, R. T., Murtadlo, A. A. A., Tamam, M. B., & Naw, S. W., "Revealing of Antiinflammatory Agent from Zingiber officinale var. Roscoe via IKK-B Inhibitor Mechanism through In Silico Simulation", SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics, 2022, 1(01), 14-19.

. Mawaddani, N., Sutiyanti, E., Widyananda, M. H., Kharisma, V. D., Turista, D. D. R., Tamam, M. B., ... & Zainul, R., "In Silico Study of Entry Inhibitor from Moringa oleifera Bioactive Compounds against SARS-CoV-2 Infection", Pharmacognosy Journal, 2022, 14(5).

. Lin, X., Li, X., & Lin, X., "A review on applications of computational methods in drug screening and design", Molecules, 2020, 25(6), 1–17.

. Dibha, A. F., Wahyuningsih, S., Kharisma, V. D., Ansori, A. N. M., Widyananda, M. H., Parikesit, A. A., ... & Zainul, R., "Biological activity of kencur (Kaempferia galanga L.) against SARS-CoV-2 main protease: In silico study", Int J Health Sci, 2022, 6(S1), 468-480.

. Patel, H., & Kukol, A., "Integrating molecular modelling methods to advance influenza A virus drug discovery", Drug Discovery Today, 2021, 26(2), 503–510.

. Aini, N. S., Kharisma, V. D., Widyananda, M. H., Ali Murtadlo, A. A., Probojati, R. T., Rahma Turista, D. D., ... & Maahury, M. F., "Bioactive Compounds from Purslane (Portulaca oleracea L.) and Star Anise (Illicium verum Hook) as SARS-CoV-2 Antiviral Agent via Dual Inhibitor Mechanism: In Silico Approach", Pharmacognosy Journal, 2022, 14(4).

. Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., Chen, X., Hou, T., & Cao, D., "ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties", Nucleic Acids Research, 2021, 49(W1), W5–W14.

. Lemkul, J., "From Proteins to Perturbed Hamiltonians: A Suite of Tutorials for the GROMACS-2018 Molecular Simulation Package [Article v1.0]", Living Journal of Computational Molecular Science, 2019, 1(1), 1–53.

. Ansori, A. N. M., Kharisma, V. D., Parikesit, A. A., Dian, F. A., Probojati, R. T., Rebezov, M., ... & Zainul, R., "Bioactive compounds from mangosteen (Garcinia mangostana L.) as an antiviral agent via dual inhibitor mechanism against SARSCoV-2: an in silico approach", Pharmacognosy Journal, 2022, 14(1).

. Probojati, R. T., Utami, S. L., Turista, D. D. R., Wiguna, A., Listiyani, P., Wijayanti, A., ... & Naw, S. W., "Revealing of Anti-inflammatory Agent from Garcinia mangostana L. Phytochemical as NF-κB Inhibitor Mechanism through In Silico Study", SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics, 2022, 1(02), 54-61.

. Kumar, A., Mehta, V., UdayBhanu, M., & Singh, T. R., "P1‐089: Flexible Docking and Simulation Studies of Natural Compounds for Inhibitors of Acetylcholinesterase for Therapeutic Intervention Related to Alzheimer's Disease", Alzheimer's & Dementia, 2016, 12, P435-P436.

. Guo, Y., Zhang, N., Sun, W., Duan, X., Zhang, Q., Zhou, Q., ... & Zhang, Y., "Bioactive polycyclic polyprenylated acylphloroglucinols from Hypericum perforatum", Organic & Biomolecular Chemistry, 2018, 16(43), 8130-8143.

. Aini, N. S., Kharisma, V. D., Widyananda, M. H., Murtadlo, A. A. A., Probojati, R. T., Turista, D. D. R., ... & Zainul, R., "In silico screening of bioactive compounds from Syzygium cumini L. and moringa oleifera L. against SARS-CoV-2 via tetra inhibitors", Pharmacognosy Journal, 2022, 14(4).

. Chen, X., Li, H., Tian, L., Li, Q., Luo, J., & Zhang, Y., "Analysis of the physicochemical properties of acaricides based on Lipinski's rule of five", Journal of Computational Biology, 2020, 27(9), 1397-1406.

. Ivanović, V., Rančić, M., Arsić, B., & Pavlović, A., "Lipinski’s rule of five, famous extensions and famous exceptions", Popular Scientific Article, 2020, 3(1), 171-177.

. Listiyani, P., Kharisma, V. D., Ansori, A. N. M., Widyananda, M. H., Probojati, R. T., Murtadlo, A. A. A., ... & Zainul, R., "In silico phytochemical compounds screening of Allium sativum targeting the Mpro of SARS-CoV-2", Pharmacognosy Journal, 2022, 14(3).

. Lee, J., & Jun, M., "Dual BACE1 and cholinesterase inhibitory effects of phlorotannins from Ecklonia cava—An in vitro and in silico study", Marine Drugs, 2019, 17(2), 91.

. Nhung, N. T., Duong, N., Phung, H. T. T., Vo, Q. V., & Tam, N. M., "In silico screening of potential β-secretase (BACE1) inhibitors from VIETHERB database", Journal of Molecular Modeling, 2022, 28(3), 60.

. Ansari, W. A., Khan, M. A., Rizvi, F., Ali, K., Hussain, M. K., Saquib, M., & Khan, M. F., "Computational screening of plant-derived natural products against SARS-CoV-2 variants", Future Pharmacology, 2022, 2(4), 558-578.

. Probojati, R. T., Murtadlo, A. A. A., Ullah, M. E., Naw, S. W., & Turista, D. D. R., "Molecular Docking Study of HIV-1 Antiretroviral Candidate via Reverse Transcriptase Inhibitor from Zingiber officinale var. Roscoe", SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics, 2022, 1(01), 26-31.

. Zainul, R., Verawati, R., Suprijono, A., Mandeli, R. S., Wulandari, A. P., Novaliendry, D., ... & Ansori, A. N. M., "In Silico Study on the Potential of Guaiacol Extract from Green Tea (Camellia sinensis) as a Stimulant for Carbanoic Anhydrase II in Renal Tubular Acidosis", Pharmacognosy Journal, 2023, 15(4).

. Dai, R., Sun, Y., Su, R., & Gao, H., "Anti-Alzheimer's disease potential of traditional Chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes", Biomedicine & Pharmacotherapy, 2022, 154, 113576.

. Zhang, Z. X., Li, Y. B., & Zhao, R. P., "Epigallocatechin gallate attenuates β-amyloid generation and oxidative stress involvement of PPARγ in N2a/APP695 cells", Neurochemical Research, 2017, 42, 468-480.

. Kaur, R., Sood, A., Lang, D. K., Bhatia, S., Al-Harrasi, A., Aleya, L., & Behl, T., "Potential of flavonoids as anti-Alzheimer’s agents: Bench to bedside", Environmental Science and Pollution Research, 2022, 29(18), 26063-26077.

. Nan, S., Wang, P., Zhang, Y., & Fan, J., "Epigallocatechin-3-gallate provides protection against Alzheimer’s disease-induced learning and memory impairments in rats", Drug Design, Development and Therapy, 2021, 2013-2024.

. Youn, K., Ho, C. T., & Jun, M., "Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: An overview of pre-clinical studies focused on β-amyloid peptide", Food Science and Human Wellness, 2022, 11(3), 483-493.

. Jiang, Y., Gao, H., & Turdu, G., "Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: A review", Bioorganic Chemistry, 2017, 75, 50-61.

. Lv, L., Yang, F., Li, H., & Yuan, J., "Brain‐targeted co‐delivery of β‐amyloid converting enzyme 1 shRNA and epigallocatechin‐3‐gallate by multifunctional nanocarriers for Alzheimer's disease treatment", IUBMB Life, 2020, 72(8), 1819-1829.

. Su, T., Monte, W. C., Hu, X., He, Y., & He, R., "Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment", Current Topics in Medicinal Chemistry, 2016, 16(5), 472-484.

. Xicota, L., Rodriguez-Morato, J., Dierssen, M., & de la Torre, R., "Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease", Current Drug Targets, 2017, 18(2), 174-195.

. Calderaro, A., Patanè, G. T., Tellone, E., Barreca, D., Ficarra, S., Misiti, F., & Laganà, G., "The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease", International Journal of Molecular Sciences, 2022, 23(23), 14835.

. Rahman, A. T., Jethro, A., Santoso, P., Kharisma, V. D., Murtadlo, A. A. A., Purnamasari, D., ... & Sari, D. A. P., "In Silico Study of the Potential of Endemic Sumatra Wild Turmeric Rhizomes (Curcuma Sumatrana: Zingiberaceae) As Anti-Cancer", Pharmacognosy Journal, 2022, 14(6).

. Murtadlo, A. A. A., Wahyuningsih, S., Turista, D. D. R., Wiguna, A., Wijayanti, A., Rachmawati, Y., ... & Ullah, M. E., "Screening of Reverse Transcriptase Inhibitor from Moringa oleifera Bioactive Compound through In Silico Study Againts HIV-1", SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics, 2022, 1(02), 46-53.

. Nhung, N. T., Duong, N., Phung, H. T. T., Vo, Q. V., & Tam, N. M., "In silico screening of potential β-secretase (BACE1) inhibitors from VIETHERB database", Journal of Molecular Modeling, 2022, 28(3), 60.

Published

2023-12-30

How to Cite

Yeop, M. Z. B. ., Humaira, A., Verawati, R., Winokan, V. M. ., Rita, R. S. ., Barroroh, H. ., & Satriawan, H. (2023). In Slico Study of Green Tea (Camellia Sinensis) Extract Epigallocatechine Gallate as an Inhibitor of Alzheimer’s and Myositis Using Beta Secretase 1. SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics, 2(02), 72–81. https://doi.org/10.24036/sainstek/vol2-iss02/32